参考文献
关键文献
Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014 Nov;134(5):e1474-502.全文 摘要
Committee on Infectious Diseases; American Academy of Pediatrics. Red book. 32nd ed. Elk Grove Village, IL: AAP; 2021.全文
Bont L, Checchia PA, Fauroux B, et al. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western countries. Infect Dis Ther. 2016 Sep;5(3):271-98.全文 摘要
American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014 Aug;134(2):415-20.全文 摘要
参考文献
1. Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014 Nov;134(5):e1474-502.全文 摘要
2. National Center for Biotechnology Information. Taxonomy database: Pneumoviridae [internet publication].全文
3. International Committee on Taxonomy of Viruses. Mononegavirales. Jul 2018 [internet publication].全文
4. Hasegawa K, Goto T, Hirayama A, et al. Respiratory virus epidemiology among US infants with severe bronchiolitis: analysis of 2 multicenter, multiyear cohort studies. Pediatr Infect Dis J. 2019 Aug;38(8):e180-3.全文 摘要
5. Jain S, Williams DJ, Arnold SR, et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015 Feb 26;372(9):835-45.全文 摘要
6. Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019 Aug 31;394(10200):757-79.全文 摘要
7. Committee on Infectious Diseases; American Academy of Pediatrics. Red book. 32nd ed. Elk Grove Village, IL: AAP; 2021.全文
8. Bont L, Checchia PA, Fauroux B, et al. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western countries. Infect Dis Ther. 2016 Sep;5(3):271-98.全文 摘要
9. Kuitunen I, Artama M, Mäkelä L, et al. Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020. Pediatr Infect Dis J. 2020 Dec;39(12):e423-7.全文 摘要
10. Varela FH, Scotta MC, Polese-Bonatto M, et al; COVIDa study group. Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: likely role of lower transmission in the community. J Glob Health. 2021 Mar 1;11:05007.全文 摘要
11. Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 23;70(29):1013-9.全文 摘要
12. Tempia S, Walaza S, Bhiman JN, et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 Jul;26(29):2001600.全文 摘要
13. Ricart S, Marcos MA, Sarda M, et al. Clinical risk factors are more relevant than respiratory viruses in predicting bronchiolitis severity. Pediatr Pulmonol. 2013 May;48(5):456-63.全文 摘要
14. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med. 1986 Jul 10;315(2):77-81. 摘要
15. Wang EE, Law BJ, Boucher FD, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996 Sep;129(3):390-5. 摘要
16. Boyce TG, Mellen BG, Mitchel EF Jr, et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr. 2000 Dec;137(6):865-70. 摘要
17. Anderson EJ, Carbonell-Estrany X, Blanken M, et al. Burden of severe respiratory syncytial virus disease among 33-35 weeks' gestational age infants born during multiple respiratory syncytial virus seasons. Pediatr Infect Dis J. 2017 Feb;36(2):160-7.全文 摘要
18. Carbonell-Estrany X, Fullarton JR, Gooch KL, et al. The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis. J Matern Fetal Neonatal Med. 2017 Jan;30(2):134-40. 摘要
19. Mauskopf J, Margulis AV, Samuel M, et al. Respiratory syncytial virus hospitalizations in healthy preterm infants: systematic review. Pediatr Infect Dis J. 2016 Jul;35(7):e229-38.全文 摘要
20. ISD Scotland. Number of hospital discharges with bronchiolitis in children 0-24 months in Scotland for the years ending December 2001-2003 [statistical data]. Edinburgh: ISD Scotland; 2006.
21. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009 Feb 5;360(6):588-98.全文 摘要
22. Zhang Y, Yuan L, Zhang Y, et al. Burden of respiratory syncytial virus infections in China: systematic review and meta-analysis. J Glob Health. 2015 Dec;5(2):020417.全文 摘要
23. Shi T, McAllister DA, O'Brien KL, et al; RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017 Sep 2;390(10098):946-58.全文 摘要
24. Li Y, Reeves RM, Wang X, et al; RSV Global Epidemiology Network; RESCEU investigators. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019 Aug;7(8):e1031-45.全文 摘要
25. Centers for Disease Control and Prevention. Respiratory syncytial virus infection (RSV): trends and surveillance. 18 Dec 2020 [internet publication].全文
26. Shi T, Denouel A, Tietjen AK, et al; RESCEU Investigators. Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis. 2020 Oct 7;222(Suppl 7):S577-83.全文 摘要
27. Colosia AD, Yang J, Hillson E, et al. The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: a systematic review. PLoS One. 2017 Aug 10;12(8):e0182321.全文 摘要
28. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004 Jan 15;189(2):233-8.全文 摘要
29. Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005 Apr 28;352(17):1749-59.全文 摘要
30. Sundaram ME, Meece JK, Sifakis F, et al. Medically attended respiratory syncytial virus infections in adults aged ≥50 years: clinical characteristics and outcomes. Clin Infect Dis. 2014 Feb;58(3):342-9.全文 摘要
31. Sieling WD, Goldman CR, Oberhardt M, et al. Comparative incidence and burden of respiratory viruses associated with hospitalization in adults in New York City. Influenza Other Respir Viruses. 2021 Sep;15(5):670-7.全文 摘要
32. Shiley KT, Lautenbach E, Lee I. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infect Control Hosp Epidemiol. 2010 Nov;31(11):1177-83.全文 摘要
33. Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 2019 Sep 10;366:l5021.全文 摘要
34. Peters TR, Crowe JE Jr. Respiratory syncytial virus. In: Long SS, Pickering LK, Prober CG, eds. Principles and practice of pediatric infectious diseases. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2008.
35. Hall CB, Douglas RG Jr, Geiman JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis. 1975 Aug;132(2):151-6. 摘要
36. Hall CB, Douglas RG Jr. Modes of transmission of respiratory syncytial virus. J Pediatr. 1981 Jul;99(1):100-3. 摘要
37. Hall CB, Douglas RG Jr, Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis. 1980 Jan;141(1):98-102. 摘要
38. Hall CB, Douglas RG Jr, Geiman JM. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr. 1976 Jul;89(1):11-5. 摘要
39. Hoffman SJ, Laham FR, Polack FP. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect. 2004 Jul;6(8):767-72. 摘要
40. Johnson JE, Gonzales RA, Olson SJ, et al. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol. 2007 Jan;20(1):108-19.全文 摘要
41. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit Care. 2006;10(4):R107.全文 摘要
42. Aherne W, Bird T, Court SD, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970 Feb;23(1):7-18.全文 摘要
43. Patarčić I, Gelemanović A, Kirin M, et al. The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis. Sci Rep. 2015 Nov 3;5:16119.全文 摘要
44. Zhou J, Zhang X, Liu S, et al. Genetic association of TLR4 Asp299Gly, TLR4 Thr399Ile, and CD14 C-159T polymorphisms with the risk of severe RSV infection: a meta-analysis. Influenza Other Respir Viruses. 2016 May;10(3):224-33.全文 摘要
45. Russell CD, Unger SA, Walton M, et al. The human immune response to respiratory syncytial virus infection. Clin Microbiol Rev. 2017 Apr;30(2):481-502.全文 摘要
46. Li Y, Pillai P, Miyake F, et al. The role of viral co-infections in the severity of acute respiratory infections among children infected with respiratory syncytial virus (RSV): a systematic review and meta-analysis. J Glob Health. 2020 Jun;10(1):010426.全文 摘要
47. Henderson FW, Collier AM, Clyde WA Jr., et al. Respiratory-syncytial-virus infections, reinfections and immunity: a prospective, longitudinal study in young children. N Engl J Med. 1979 Mar 8;300(10):530-4. 摘要
48. Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 2005 Jan;115(1):e7-14.全文 摘要
49. Cai W, Buda S, Schuler E, et al. Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes. Influenza Other Respir Viruses. 2020 Nov;14(6):658-70.全文 摘要
50. Checchia PA, Paes B, Bont L, et al. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among infants with congenital heart disease. Infect Dis Ther. 2017 Mar;6(1):37-56.全文 摘要
51. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr. 1992 Sep;121(3):348-54. 摘要
52. Anderson J, Do LAH, Wurzel D, et al. Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity. Thorax. 2021 Sep;76(9):942-50. 摘要
53. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003 Nov;143(5 Suppl):S118-26. 摘要
54. National Institute for Health and Care Excellence. Bronchiolitis in children: diagnosis and management. Aug 2021 [internet publication].全文
55. Wennergren G, Kristjánsson S. Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. Eur Respir J. 2001 Dec;18(6):1044-58.全文 摘要
56. Grut V, Söderström L, Naumburg E. National cohort study showed that infants with Down's syndrome faced a high risk of hospitalisation for the respiratory syncytial virus. Acta Paediatr. 2017 Jul 21;106(9):1519-24. 摘要
57. Chan M, Park JJ, Shi T, et al. The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: a systematic review and meta-analysis. J Glob Health. 2017 Dec;7(2):020413.全文 摘要
58. Beckhaus AA, Castro-Rodriguez JA. Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysis. Pediatrics. 2018 Sep;142(3):.全文 摘要
59. Mitra S, El Azrak M, McCord H, et al. Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis. J Pediatr. 2018 Dec;203:92-100.e3.全文 摘要
60. Acosta PL, Caballero MT, Polack FP. Brief history and characterization of enhanced respiratory syncytial virus disease. Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95.全文 摘要
61. Papi A, Ison MG, Langley JM, et al. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med. 2023 Feb 16;388(7):595-608. 摘要
62. Pons JM, Tebé C, Paladio N, et al. Meta-analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection. Acta Paediatr. 2011 Mar;100(3):324-9. 摘要
63. Kampmann B, Madhi SA, Munjal I, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023 Apr 20;388(16):1451-64. 摘要
64. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998 Sep;102(3 Pt 1):531-7. 摘要
65. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003 Oct;143(4):532-40. 摘要
66. Checchia PA, Nalysnyk L, Fernandes AW, et al. Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis. Pediatr Crit Care Med. 2011 Sep;12(5):580-8. 摘要
67. Andabaka T, Nickerson JW, Rojas-Reyes MX, et al. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev. 2013;(4):CD006602.全文 摘要
68. Chiu SN, Shao PL, Chen HC, et al. Risk of respiratory syncytial virus infection in cyanotic congenital heart disease in a subtropical area. J Pediatr. 2016 Apr;171:25-30.e1. 摘要
69. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014 Aug;134(2):415-20.全文 摘要
70. Hu JR, Robinson JL. Treatment of respiratory syncytial virus with palivizumab: a systematic review. World J Pediatr. 2010 Nov;6(4):296-300.全文 摘要
71. Robinson KA, Odelola OA, Saldanha IJ. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Database Syst Rev. 2016;(7):CD007743.全文 摘要
72. American Academy of Pediatrics. Updated guidance: use of palivizumab prophylaxis to prevent hospitalization from severe respiratory syncytial virus infection during the 2021-2022 RSV season. Dec 2021 [internet publication].全文
73. Garegnani L, Styrmisdóttir L, Roson Rodriguez P, et al. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database Syst Rev. 2021 Nov 16;11:CD013757.全文 摘要
74. Griffin MP, Khan AA, Esser MT, et al. Safety, tolerability, and pharmacokinetics of MEDI8897, the respiratory syncytial virus prefusion F-targeting monoclonal antibody with an extended half-life, in healthy adults. Antimicrob Agents Chemother. 2017 Feb 23;61(3):e01714-16.全文 摘要
75. American Academy of Pediatrics. American Academy of Pediatrics recommends medication to prevent RSV be given to all infants and urges equitable access. Aug 2023 [internet publication].全文
76. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP): ACIP recommendations. Sep 2023 [internet publication].全文
77. Griffin MP, Yuan Y, Takas T, et al; Nirsevimab Study Group. Single-dose nirsevimab for prevention of RSV in preterm infants. N Engl J Med. 2020 Jul 30;383(5):415-25.全文 摘要
78. Hammitt LL, Dagan R, Yuan Y, et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022 Mar 3;386(9):837-46. 摘要
79. Domachowske JB, Khan AA, Esser MT, et al. Safety, tolerability and pharmacokinetics of MEDI8897, an extended half-life single-dose respiratory syncytial virus prefusion F-targeting monoclonal antibody administered as a single dose to healthy preterm infants. Pediatr Infect Dis J. 2018 Sep;37(9):886-92.全文 摘要
80. Mansbach JM, Camargo CA Jr. Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma. Clin Lab Med. 2009 Dec;29(4):741-55.全文 摘要
81. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003 Nov;143(5 Suppl):S112-7. 摘要
82. Church NR, Anas NG, Hall CB, et al. Respiratory syncytial virus-related apnea in infants: demographics and outcome. Am J Dis Child. 1984 Mar;138(3):247-50. 摘要
83. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001 Sep 15;33(6):792-6.全文 摘要
84. Coultas JA, Smyth R, Openshaw PJ. Respiratory syncytial virus (RSV): a scourge from infancy to old age. Thorax. 2019 Oct;74(10):986-93.全文 摘要
85. Moreira LP, Watanabe ASA, Camargo CN, et al. Respiratory syncytial virus evaluation among asymptomatic and symptomatic subjects in a university hospital in Sao Paulo, Brazil, in the period of 2009-2013. Influenza Other Respir Viruses. 2018 May;12(3):326-30.全文 摘要
86. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 1999 Sep;160(3):791-5.全文 摘要
87. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis. 2008 Feb 1;46(3):402-12.全文 摘要
88. Shah DP, Ghantoji SS, Ariza-Heredia EJ, et al. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood. 2014 May 22;123(21):3263-8.全文 摘要
89. Bruning AHL, Leeflang MMG, Vos JMBW, et al. Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis. Clin Infect Dis. 2017 Sep 15;65(6):1026-32.全文 摘要
90. Nicholson KG, Abrams KR, Batham S, et al. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds. Health Technol Assess. 2014 May;18(36):1-274, vii-viii. 摘要
91. Krasinski K, LaCourture R, Holzman RS, et al. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr. 1990 Jun;116(6):894-8. 摘要
92. Doan Q, Enarson P, Kissoon N, et al. Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev. 2014;(9):CD006452.全文 摘要
93. Ko F, Drews SJ. The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization. Expert Rev Mol Diagn. 2017 Oct;17(10):917-31. 摘要
94. Chartrand C, Tremblay N, Renaud C, et al. Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.全文 摘要
95. Simpson W, Hacking PM, Court SD, et al. The radiological findings in respiratory syncytial virus infection in children. II: the correlation of radiological categories with clinical and virological findings. Pediatr Radiol. 1974;2(3):155-60. 摘要
96. Simpson W, Hacking PM, Court SD, et al. The radiological findings in respiratory syncytial virus infection in children. Part I: definitions and interobserver variation in the assessment of abnormalities on the chest x-ray. Pediatr Radiol. 1974;2(2):97-100. 摘要
97. Friis B, Eiken M, Hornsleth A, et al. Chest x-ray appearances in pneumonia and bronchiolitis: correlation to virological diagnosis and secretory bacterial findings. Acta Paediatr Scand. 1990 Feb;79(2):219-25. 摘要
98. Chatzis O, Darbre S, Pasquier J, et al. Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study. BMC Infect Dis. 2018 Mar 6;18(1):111.全文 摘要
99. Hall CB. Respiratory syncytial virus: a continuing culprit and conundrum. J Pediatr. 1999 Aug;135(2 Pt 2):2-7. 摘要
100. Bruhn FW, Mokrohisky ST, McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr. 1977 Mar;90(3):382-6. 摘要
101. Hall CB. Respiratory syncytial virus and sudden infant death. N Engl J Med. 1979 Jun 21;300(25):1440-1. 摘要
102. Anas N, Boettrich C, Hall CB, et al. The association of apnea and respiratory syncytial virus infection in infants. J Pediatr. 1982 Jul;101(1):65-8. 摘要
103. Kneyber MC, Brandenburg AH, de Groot R, et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr. 1998 Apr;157(4):331-5. 摘要
104. Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med. 2006 Oct;48(4):441-7. 摘要
105. Turner T, Wilkinson F, Harris C, et al. Evidence based guideline for the management of bronchiolitis. Aust Fam Physician. 2008 Jun;37(6 Spec No):6-13. 摘要
106. Stempel HE, Martin ET, Kuypers J, et al. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr. 2009 Jan;98(1):123-6. 摘要
107. Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis. 2004 Feb 15;189(4):706-10.全文 摘要
108. Koetz A, Nilsson P, Linden M, et al. Detection of human coronavirus NL63, human metapneumovirus and respiratory syncytial virus in children with respiratory tract infections in south-west Sweden. Clin Microbiol Infect. 2006 Nov;12(11):1089-96.全文 摘要
109. Mansbach JM, McAdam AJ, Clark S, et al. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med. 2008 Feb;15(2):111-8.全文 摘要
110. Yuksel H, Yilmaz O, Akcali S, et al. Common viral etiologies of community acquired lower respiratory tract infections in young children and their relationship with long term complications [in Turkish]. Mikrobiyol Bul. 2008 Jul;42(3):429-35. 摘要
111. Caballero MT, Polack FP, Stein RT. Viral bronchiolitis in young infants: new perspectives for management and treatment. J Pediatr (Rio J). 2017 Nov - Dec;93(suppl 1):75-83.全文 摘要
112. O'Brien S, Craig S, Babl FE, et al; Paediatric Research in Emergency Departments International Collaborative (PREDICT) Network, Australasia. 'Rational use of high-flow therapy in infants with bronchiolitis. What do the latest trials tell us?' A Paediatric Research in Emergency Departments International Collaborative perspective. J Paediatr Child Health. 2019 Jul;55(7):746-52. 摘要
113. Combret Y, Prieur G, LE Roux P, et al. Non-invasive ventilation improves respiratory distress in children with acute viral bronchiolitis: a systematic review. Minerva Anestesiol. 2017 Jun;83(6):624-637.全文 摘要
114. Downes JJ, Wood DW, Striker TW, et al. Acute respiratory failure in infants with bronchiolitis. Anesthesiology. 1968 May-Jun;29(3):426-34. 摘要
115. Lodrup Carlsen KC, Carlsen KH. Inhaled nebulized adrenaline improves lung function in infants with acute bronchiolitis. Respir Med. 2000 Jul;94(7):709-14. 摘要
116. Modl M, Eber E, Weinhandl E, et al. Assessment of bronchodilator responsiveness in infants with bronchiolitis. A comparison of the tidal and the raised volume rapid thoracoabdominal compression technique. Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):763-8. 摘要
117. Sanchez I, De Koster J, Powell RE, et al. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr. 1993 Jan;122(1):145-51. 摘要
118. Heikkilä P, Renko M, Korppi M. Hypertonic saline inhalations in bronchiolitis - a cumulative meta-analysis. Pediatr Pulmonol. 2018 Feb;53(2):233-42. 摘要
119. Everard ML, Hind D, Ugonna K, et al; SABRE Study Team. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax. 2014 Dec;69(12):1105-12.全文 摘要
120. Zhang L, Mendoza-Sassi RA, Klassen TP, et al. Nebulized hypertonic saline for acute bronchiolitis: a systematic review. Pediatrics. 2015 Oct;136(4):687-701. 摘要
121. von Lilienfeld-Toal M, Berger A, Christopeit M, et al. Community acquired respiratory virus infections in cancer patients: guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology. Eur J Cancer. 2016 Nov;67:200-12.全文 摘要
122. Hynicka LM, Ensor CR. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients. Ann Pharmacother. 2012 Apr;46(4):558-66. 摘要
123. Dignan FL, Clark A, Aitken C, et al; Haemato-oncology Task Force of the British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation; UK Clinical Virology Network. BCSH/BSBMT/UK Clinical Virology Network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. Br J Haematol. 2016 May;173(3):380-93. 摘要
124. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011 Mar 10;117(10):2755-63.全文 摘要
125. Marcelin JR, Wilson JW, Razonable RR; Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transpl Infect Dis. 2014 Apr;16(2):242-50. 摘要
126. Rodriguez WJ, Gruber WC, Groothuis JR, et al. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics. 1997 Dec;100(6):937-42. 摘要
127. Hemming VG, Rodriguez W, Kim HW, et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother. 1987 Dec;31(12):1882-6.全文 摘要
128. Levin D, Tribuzio M, Green-Wrzesinki T, et al. Empiric antibiotics are justified for infants with respiratory syncytial virus lower respiratory tract infection presenting with respiratory failure: a prospective study and evidence review. Pediatr Crit Care Med. 2010 May;11(3):390-5. 摘要
129. Farley R, Spurling GK, Eriksson L, et al. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014 Oct 9;(10):CD005189.全文 摘要
130. Ermers MJ, Rovers MM, van Woensel JB, et al. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial. BMJ. 2009 Mar 31;338:b897.全文 摘要
131. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013 Jun 4;(6):CD004878.全文 摘要
132. Alarcón-Andrade G, Cifuentes L. Should systemic corticosteroids be used for bronchiolitis? [in spa]. Medwave. 2018 May 7;18(3):e7207.全文 摘要
133. Alarcón-Andrade G, Cifuentes L. Do inhaled corticosteroids have a role for bronchiolitis? [in spa]. Medwave. 2018 Apr 17;18(2):e7183.全文 摘要
134. Enriquez A, Chu IW, Mellis C, et al. Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months. Cochrane Database Syst Rev. 2012 Nov 14;(11):CD008395.全文 摘要
135. Chalumeau M, Duijvestijn YC. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev. 2013 May 31;(5):CD003124.全文 摘要
136. Liet JM, Ducruet T, Gupta V, et al. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev. 2015 Sep 18;(9):CD006915.全文 摘要
137. Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008 Oct 15;178(8):854-60.全文 摘要
138. Chandelia S, Kumar D, Chadha N, et al. Magnesium sulphate for treating acute bronchiolitis in children up to two years of age. Cochrane Database Syst Rev. 2020 Dec 14;12(12):CD012965.全文 摘要
139. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014 Jun 17;2014(6):CD001266.全文 摘要
140. Huntjens DRH, Ouwerkerk-Mahadevan S, Brochot A, et al. Population pharmacokinetic modeling of JNJ-53718678, a novel fusion inhibitor for the treatment of respiratory syncytial virus: results from a phase I, double-blind, randomized, placebo-controlled first-in-human study in healthy adult subjects. Clin Pharmacokinet. 2017 Nov;56(11):1331-42. 摘要
141. DeVincenzo JP, Whitley RJ, Mackman RL, et al. Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med. 2014 Aug 21;371(8):711-22.全文 摘要
142. Fujiogi M, Goto T, Yasunaga H, et al. Trends in bronchiolitis hospitalizations in the United States: 2000-2016. Pediatrics. 2019 Dec;144(6):e20192614.全文 摘要
143. Sung RY, Murray HG, Chan RC, et al. Seasonal patterns of respiratory syncytial virus infection in Hong Kong: a preliminary report. J Infect Dis. 1987 Sep;156(3):527-8. 摘要
144. Scheltema NM, Gentile A, Lucion F, et al. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017 Oct;5(10):e984-91.全文 摘要
145. Driscoll AJ, Arshad SH, Bont L, et al. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine. 2020 Mar 4;38(11):2435-48.全文 摘要
146. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000 May;161(5):1501-7.全文 摘要
147. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999 Aug 14;354(9178):541-5. 摘要
148. Lu S, Hartert TV, Everard ML, et al. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood. Pediatr Pulmonol. 2016 Dec;51(12):1382-92. 摘要
149. Scheltema NM, Nibbelke EE, Pouw J, et al. Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. Lancet Respir Med. 2018 Apr;6(4):257-64. 摘要
150. Hall CB, Douglas RG Jr. Nosocomial respiratory syncytial viral infections: should gowns and masks be used? Am J Dis Child. 1981 Jun;135(6):512-5. 摘要
151. Gala CL, Hall CB, Schnabel KC, et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA. 1986 Nov 21;256(19):2706-8. 摘要
152. Agah R, Cherry JD, Garakian AJ, et al. Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections: routine isolation procedure vs routine procedure supplemented by use of masks and goggles. Am J Dis Child. 1987 Jun;141(6):695-7. 摘要
153. Leclair JM, Freeman J, Sullivan BF, et al. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med. 1987 Aug 6;317(6):329-34. 摘要
内容使用需遵循免责声明